Commentary

Emerging blood-based biomarkers for Alzheimer disease

Lynn M. Bekris, PhD and James B. Leverenz, MD
Cleveland Clinic Journal of Medicine September 2020, 87 (9) 537-539; DOI: https://doi.org/10.3949/ccjm.87a.20133

Article Information

vol. 87 no. 9 537-539
DOI 
https://doi.org/10.3949/ccjm.87a.20133
PubMed 
32868302
Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online August 31, 2020.
Copyright & Usage 
Copyright © 2020 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Lynn M. Bekris, PhD⇑
  1. Associate Staff, Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic; Assistant Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  1. Address:
    Lynn M. Bekris, PhD, Genomic Medicine Institute, R4, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; bekrisl{at}ccf.org
  1. James B. Leverenz, MD
  1. Director, Cleveland Lou Ruvo Center for Brain Health, Neurological Institute, and Joseph Hahn, MD, Endowed Chair of the Cleveland Clinic Neurological Institute, Cleveland Clinic

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects